CV Lattes
ORCID
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto de Psiquiatria Doutor Antonio Carlos Pacheco e Silva (IPq) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciencias biologicas from Universidade Metropolitana de São Paulo (2005), master's at Psiquiatria from Fundação Faculdade de Medicina (2009) and doctorate at Psiquiatria from Faculdade de Medicina USP (2015). Has experience in Medicine, focusing on Psychiatry, acting on the following subjects: lítio, cultura primária de neurônios, telomeros, neuronal cell and neuroproteção. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Alzheimer's disease (AD) is a neurodegenerative condition and the prevalent cause of dementia worldwide. Although its etiology has not been yet completely clarified, there is growing consensus on its multifactorial nature. Therefore, the need of multi-target strategies is clear, and the current state of the art in nanomaterials is now mature enough to offer flexible platforms to develop m…
Recently, special attention has been given to the possible neuroprotective effects of lithium, especially by the discovery of its regulatory effects on pro and anti-apoptotic proteins. Lithium substantially increases the cytoprotective proteins expression in the central nervous system, both in rat cortex and in human cells of neuronal origin. In addition to neuroprotective actions, it aid…
In recent years we have given special attention to the possible neuroprotective effects of lithium, especially by the discovery of its regulatory effects on protein pro and anti-apoptotic. The lithium substantially increases the expression of cytoprotective proteins in central nervous system either in rat cortex as in human cells of neural origin. Besides neuroprotective effects, it assis…
Schizophrenia is an incapacitating mental disorder, which affects 5/1000 people in Brazil. The physiopathology of this disease is not completed elucidated and its treatment causes important collateral effects, such as motor disturbances, metabolic dysregulation and agranulocytosis. Multiple evidence show a pro-oxidative status in the disease, which can lead to oxidative stress damage, inc…
(Only some records are available in English at this moment)
| 1 / 1 | Ongoing grants |
| 4 / 4 | Completed scholarships in Brazil |
| 5 / 5 | All research grants and scholarships |
| Associated processes | |